Boehringer Ingelheim (Canada) Ltd. Partners with TEC Edmonton in support of the TEC Health Accelerator

June 30, 2016 – Edmonton, AB – The Canadian headquarters of the globally-operated pharmaceutical company, Boehringer Ingelheim has joined business incubator TEC Edmonton’s group of industry partners to deliver advanced services and resources to Alberta entrepreneurs through the TEC Health Accelerator program.

Led by TEC Edmonton, in partnership with Innovate Calgary, the TEC Health Accelerator is […]

By |June 30th, 2016|TEC Company News|0 Comments

Coming Soon: TEC Edmonton’s New “Accelerator Space”

A prime downtown Edmonton storefront location, which has lain fallow for many months, will soon burst into life.

On Monday, June 27, 2016, with Alberta’s Minister of Economic Development Deron Bilous in attendance, TEC Edmonton CEO Chris Lumb announced the launch of TEC Edmonton’s “accelerator space” on the ground floor of Enterprise Square, looking out onto […]

By |June 29th, 2016|TEC Company News|0 Comments

Edmonton Organ Transplant Company Tevosol Secures Financing

EDMONTON, AB–(Marketwired – June 29, 2016) – Medical device company Tevosol is one step closer to improving the lives of patients awaiting organ transplants after securing $2 million in financing. This TEC Edmonton client and University of Alberta spinoff company has designed a medical device that keeps critical organs such as hearts and lungs viable […]

By |June 29th, 2016|TEC Clients, TEC Company News|0 Comments

Crowd funding: Two points of view

It’s been a long time coming, supporters say, but the removal of barriers, along with investor incentives to encourage “crowd funding” will soon be forthcoming from the provincial government and the Alberta Securities Commission.

“Crowd funding” is a means by which small start-up companies can raise investment capital through online websites. Young companies can tout their […]

By |June 28th, 2016|Innovation Community, TEC Venture Angels|0 Comments

Novel Bio-markers for Diagnosis and Treatment of Stress

Description
Dr. Dean Befus at the University of Alberta in collaboration with Dr. Thomas Ritz at the Southern Methodist University have identified calcium-binding protein spermatid specific 1 (CABS1) protein forms that can be used as predictive, diagnostic, and prognostic biomarkers for stress in humans.
BACKGROUND
Cortisol is one of the best known and most widely used biomarkers for […]

MTI Signs Multi-Million Dollar Licensing Agreement

There were fist bumps and high-fives around Metabolomic Technologies Inc’s (MTI) office, and by early May, 2016, all was official and announced.

MTI had made its first major sale. The long-time TEC Edmonton client has signed a multi-million-dollar licensing and distribution agreement with Pennsylvania-based Atlantic Diagnostic Laboratories (ADL).

ADL will be selling MTI’s PolypDx™ diagnostic test to […]

By |June 16th, 2016|TEC Clients|0 Comments

Dry Powder Based Respirable Bacteriophage Compositions

Description
Background: Bacteriophages are viruses that target and eliminate specific bacteria. They are potential alternatives to chemical antibiotics and are under development as therapeutics for various infectious diseases, including respiratory tract infections. University of Alberta researchers recently demonstrated the therapeutic effectiveness of a nebulized phage therapy in a study of mice with respiratory infections caused by […]

By |June 15th, 2016|Licensing Opportunities|0 Comments

MagnetTx: New Innovations in Cancer Research

There’s precious few changes in this world that, in a few minutes, can have a transformational impact.

But this is one of them, and in cancer treatment, no less.

Dr. Gino Fallone and Brad Murray, medical physicists at the Cross Cancer Institute, have figured out how to do something that was heretofore impossible.

Say you have a cancerous […]

TEC Client VaxAlta Announces Publication of Research

TEC client and University of Alberta spin-off company VaxAlta recently announced the publication of their research in the May 25, 2016 issue of Nature Scientific Reports. Jason Ding, Acting CFO of VaxAlta, is also an Executive-in-Residence of TEC and the Director of the TEC Health Accelerator program.

Full Press Release:
VaxAlta Inc. Announces Publication of Research on […]

By |June 6th, 2016|Innovation Community, TEC Clients|0 Comments